2014
DOI: 10.1186/1471-2334-14-491
|View full text |Cite
|
Sign up to set email alerts
|

A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments

Abstract: BackgroundIn this paper we study the distribution of leukocyte populations and of cytokine-producing cells in the spleen of a patient with visceral leishmaniasis resistant to clinical treatment. It is the first attempt to compare the distribution of leukocyte populations and cytokine-producing cells in the splenic compartments of a patient with visceral leishmaniasis with those observed in patients without the disease.Case presentationA 25-year-old male, farmer, was hospitalized on several occasions with diagn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 11 publications
0
11
0
Order By: Relevance
“…Amphotericin B, particularly in liposomal formulation ( 84 ), has become the drug of choice in developed countries and where antimony resistance is problematic; but issues of cost and toxicity remain. Also, there are already clinical cases of treatment failure related to liposomal amphotericin B ( 67 , 85 ). The onset of immunosuppression is a critical event during the progression of VL in a susceptible population.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Amphotericin B, particularly in liposomal formulation ( 84 ), has become the drug of choice in developed countries and where antimony resistance is problematic; but issues of cost and toxicity remain. Also, there are already clinical cases of treatment failure related to liposomal amphotericin B ( 67 , 85 ). The onset of immunosuppression is a critical event during the progression of VL in a susceptible population.…”
Section: Discussionmentioning
confidence: 99%
“…A new approach to develop treatment strategy against VL in resistance cases has to take into account not only by the development of new leishmanicidal drugs but also by the drugs that could reverse the anergic immune response and pathophysiological changes during VL, such as hypocholesterolemia and splenic neovascularization. The use of an anti-vascular therapy (with Sm, for instance) could be an alternative choice to splenectomy in cases of failure treatment for lipossomal Amphotericin B ( 67 , 85 ).…”
Section: Discussionmentioning
confidence: 99%
“…The most evident change is spleen enlargement. In humans, the spleen may reach the right lower quadrant of the abdomen and gives rise to hypersplenism, a syndrome characterized by anemia, thrombocytopenia and low white blood cell counts (Dos-Santos et al, 2014 ). In fact, a decrease in spleen size is used as a parameter of therapeutic response in human VL (Kip et al, 2015 ).…”
Section: Spleen Disorganization In Vlmentioning
confidence: 99%
“…Although the spleen compartments contain the crucial elements to effectively respond to Leishmania infection, in severe cases of disease, the spleen undergoes sequential changes of WP hyperplasia, atrophy and disruption (11). Spleen enlargement leads to hypersplenism syndrome with increased leukocyte and platelet retention and destruction of blood cells (12,13).…”
Section: Introductionmentioning
confidence: 99%